Indeed, it was previously demonstrated that as compared with healthy fibroblasts, the basal level of NAD+ and the NAD+/NADH ratio were both significantly lower in PD patient fibroblasts and increasing the NAD+/NADH ratio by pharmacological treatment enhanced SIRT1 deacetylation activity [11]. Here, SIRT1 is linked to Parkinson disease.